172. Use of Transcriptional signatures to differentiate pathogen- and treatment-specific host responses in patients with bacterial bloodstream infections. Thaden, J.T., Rahn, R., Ruffin, F., Gjertson, D.W., Hoffmann, A., Fowler, V.G., Yeaman, M.R., MRSA Systems Immunology Group Journal of Infectious Diseases, 229 (5), pp.1535, 2023. PMID: 38001039, PMC11095544